Carla J. de Boer

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Pieter Sonneveld, Meletios Α. Dimopoulos, Mario Boccadoro et al. · New England Journal of Medicine · 2023 · 435 citations · Full text

Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver

Carla J. de Boer, J. Han van Krieken, Connie M. Janssen‐van Rhijn et al. · The Journal of Pathology · 1999 · 235 citations

Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study

Irene Braña, Antonio Calles, Patricia LoRusso et al. · Targeted Oncology · 2014 · 208 citations

Solid Tumors, Medicine, Immunology +8

Mantle-cell lymphoma: a population-based clinical study.

Gerjo A. Velders, Hanneke C. Kluin‐Nelemans, Carla J. de Boer et al. · Journal of Clinical Oncology · 1996 · 188 citations

Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.

Carla J. de Boer, J. Han van Krieken, Hanneke C. Kluin‐Nelemans et al. · PubMed · 1995 · 125 citations